Clinical Trial Update: Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating recurrence of hepatocellular carcinoma in chronic hepatitis C patients treated with direct-acting antivirals; no result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• Direct-acting antivirals (direct-acting antivirals)

Snippet

Sponsor: Ain Shams University | Conditions: Hepatocellular Carcinoma, Hepatitis C, Chronic | Phase 3 | Status: UNKNOWN